Ronald van Vollenhoven

51PUBLICATIONS
196CO-AUTHORS
Rheumatology and arthritisAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesRural clinical health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Aug 05, 2026
Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic.

|Apr 08, 2026
Efficacy and safety of anifrolumab in patients with systemic lupus erythematosus without prior immunosuppressant use: post hoc analysis of phase 3 TULIP-1 and TULIP-2 trials.

Andrea Doria, Ronald F van Vollenhoven, Eric F Morand

|Dec 12, 2025
Patient-physician discordance in assessing SLE disease activity: longitudinal analysis of disease-related variables and quality of life.

Agner R Parra Sánchez, Irene E M Bultink, Jos W R Twisk

|Oct 06, 2025
Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective.

Elena W Y Hsieh, James B Chung, Afsah Amin

|Sep 08, 2025
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus.

Cristina Arriens, Eric F Morand, Anca D Askanase

|Aug 22, 2025
Advancing treat-to-target in SLE: a pilot study using a clinical decision support system.

Agner R Parra Sánchez, Koen Vos, Odile van Hall

Pageof 9

Frequent Collaborators

12 joint publications

Murray Urowitz

11 joint publications

Michelle Petri

10 joint publications

Sang-Cheol Bae

9 joint publications

Cynthia Aranow